A General Synthetic Approach for Designing Epitope Targeted Macrocyclic Peptide Ligands. (17th September 2015)

• Record Type: Journal Article
• Authors: Das, Samir; Nag, Arundhati; Liang, JingXin; Bunck, David N.; Umeda, Aiko; Farrow, Blake; Coppock, Matthew B.; Sarkes, Deborah A.; Finch, Amethist S.; Agnew, Heather D.; Pitram, Suresh; Lai, Bert; Yu, Mary Beth; Museth, A. Katrine; Deyle, Kaycie M.; Lepe, Bianca; Rodriguez‐Rivera, Frances P.; McCarthy, Amy; Alvarez‐Villalonga, Belen; Chen, Ann; Heath, John; Stratis‐Cullum, Dimitra N.; Heath, James R.
• Is Part Of: Angewandte Chemie. Volume 127:Number 45(2015)
• Page Start: 13417
• Page End: 13422
• Publication Date: 2015-09-17
• Subjects: Chemistry -- Periodicals; 540
• DOI: 10.1002/ange.201505243
• Languages: English
• ISSNs: 0044-8249

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>We describe a general synthetic strategy for developing high‐affinity peptide binders against specific epitopes of challenging protein biomarkers. The epitope of interest is synthesized as a polypeptide, with a detection biotin tag and a strategically placed azide (or alkyne) presenting amino acid. This synthetic epitope (SynEp) is incubated with a library of complementary alkyne or azide presenting peptides. Library elements that bind the SynEp in the correct orientation undergo the Huisgen cycloaddition, and are covalently linked to the SynEp. Hit peptides are tested against the full‐length protein to identify the best binder. We describe development of epitope‐targeted linear or macrocycle peptide ligands against 12 different diagnostic or therapeutic analytes. The general epitope targeting capability for these low molecular weight synthetic ligands enables a range of therapeutic and diagnostic applications, similar to those of monoclonal antibodies.</p> </abstract>